More and more frequent vaccine doses than in other countries reduce mortality in COVID-19 in nursing homes. This is shown by a Swedish study, led by Anders Johansson and Mattias Forsell, Umeå University, which was published in The Lancet Infectious Diseases.
More and more frequent vaccine doses than in other countries reduce mortality in COVID-19 in nursing homes. This is shown by a Swedish study, led by Anders Johansson and Mattias Forsell, Umeå University, which wasIn the fight against COVID-19, researchers have carefully studied the effectiveness of top-up doses of mRNA vaccine, i.e. doses four to six for people in special nursing homes.
People older than 80 years often show a weaker antibody response after the first doses of the vaccine. The study found a strong correlation between the concentration of specific antibodies against the virus and the risk of COVID-19-relatedThe researchers analyzed mortality data for 3,029 adults with an average age of 87 between September 2021 and May 2023. The individuals were divided into two groups: those who were infected with SARS-CoV-2 and those who were not.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
NI busker wows audiences as he gets through to Swedish Idol live showsJordan Rawling's music previously featured on the Love Island semi-final
Weiterlesen »
Victim of hate crime says 'love will win'Syrian businessman says he will move his new shop after repeated racist attacks on Donegall Road.
Weiterlesen »
Avanti West Coast given nine-year contract renewal for Glasgow to London trainsAvanti has been repeatedly criticised by passengers for poor service and repeated cancellations in recent years..
Weiterlesen »
Early convalescent plasma use—helpful in avoiding severe COVID—also may lower long COVID riskFindings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions—commonly known as long COVID—if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.
Weiterlesen »
Cell therapy can reduce risk of death from COVID-19 by 60%, study findsThe use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.
Weiterlesen »